TherapeuticsMD Inc logo

TherapeuticsMD Inc

$ 6.73 -0.29 (-4.13%) 08:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 62.71M
Enterprise V:
$ 139.74M
Volume:
39.73K
Avg Vol (2M):
362.57K
Also Trade In:
Volume:
39.73K
Market Cap $:
62.71M
PE Ratio:
At Loss
Avg Vol (2-Month):
362.57K
Enterprise Value $:
139.74M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 0.26
Equity-to-Asset -0.18
Debt-to-Equity -3.83
Debt-to-EBITDA -17.14
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.36
Distress
Grey
Safe
Beneish M-Score -3.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.3
9-Day RSI 41.41
14-Day RSI 41.61
6-1 Month Momentum % -52.78
12-1 Month Momentum % -73.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.6
Quick Ratio 0.56
Cash Ratio 0.16
Days Inventory 140.18
Days Sales Outstanding 149.43
Days Payable 331.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.4

Financials (Next Earnings Date:2022-11-11 Est.)

TXMD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TXMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 91.978
EPS (TTM) ($) -3.801
Beta 1.27
Volatility % 117.48
14-Day RSI 41.61
14-Day ATR ($) 0.711255
20-Day SMA ($) 7.9105
12-1 Month Momentum % -73.34
52-Week Range ($) 1.99 - 40.9
Shares Outstanding (Mil) 9.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TherapeuticsMD Inc Filings

Document Form Filing Date
No Filing Data

TherapeuticsMD Inc Analysis

Share your research

Headlines

See More
No news.